Case Study: PharmAthene V. SIGA
On Sept. 22, 2011, the Delaware Chancery Court awarded PharmAthene Inc. a 50-percent share of profits above a certain threshold amount from sales of SIGA Technology Inc.'s pharmaceutical product known as...To view the full article, register now.
Already a subscriber? Click here to view full article